Treat-to-target approach in the management of inflammatory Bowel disease

Keyphrases

• Inflammatory Bowel Disease 100%
• Treat-to-target 100%
• Disease Control 50%
• Therapeutic Goals 50%
• Randomized Controlled Trial 50%
• Disease Progression 50%
• Substantial Change 50%
• Endoscopic Remission 50%
• Clinical Remission 50%
• Fecal Calprotectin 50%
• Expert Recommendation 50%
• New Disease 50%
• Therapy Goals 50%
• Intestinal Injury 50%
• Quality of Life Improvement 50%
• Symptom Control 50%
• Small Molecule Therapy 50%
• Control Targets 50%
• Histological Healing 50%
• Mucosal Healing 50%

Medicine and Dentistry

• Inflammatory Bowel Disease 100%
• Disease 50%
• Quality of Life 50%
• Biological Marker 50%
• Randomized Controlled Trial 50%
• Disease Exacerbation 50%
• Biological Product 50%
• Faecal Calprotectin 50%
• Intestine Injury 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Inflammatory Bowel Disease 100%
• Disease 50%
• Biological Marker 50%
• Disease Exacerbation 50%
• Remission 50%
• Randomized Controlled Trial 50%
• Biological Product 50%
• Calgranulin 50%
• Intestine Injury 50%